Abstract
Biofilms are among the most important causes of nosocomial and recurrent infections as biofilms confer antibiotic resistance to pathogenic bacteria and protect them from the host’s immune system. Thus, it is imperative to investigate effective therapeutic agents to counteract biofilms. As an important signaling molecule, Nitric Oxide (NO) plays a crucial role in various biological and pathological processes. NO could disperse biofilm and restore the drug sensitivity by reducing intracellular cyclic-diguanosine monophosphate (c-di-GMP) levels. This review highlights recent advances on antibacterial and antibiofilm effects of NO when NO was co-administered with other antimicrobial agents. A significant improvement in drug permeability and biofilm cell targeting and reduced cytotoxicity could be attained with this strategy. In this review, we briefly lay out challenges and propose future directions in this appealing avenue of research on NO-based therapy for biofilm eradication.
Keywords: Nitric oxide (NO), Biofilm eradication, Antibiotic resistance, Bis-(3′-5′)-cyclic-diguanosine monophosphate (c-di- GMP), Antibacterial therapy, Pathogenic infection.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:The Insights and Perspectives of Nitric Oxide-mediated Biofilm Eradication
Volume: 21 Issue: 24
Author(s): Mingke Yuan, Tao Sun, Jianbing Wu, Yue Fei, Yueqi Yang, Yong Ling, Yihua Zhang and Zhangjian Huang*
Affiliation:
- State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing210009,China
Keywords: Nitric oxide (NO), Biofilm eradication, Antibiotic resistance, Bis-(3′-5′)-cyclic-diguanosine monophosphate (c-di- GMP), Antibacterial therapy, Pathogenic infection.
Abstract: Biofilms are among the most important causes of nosocomial and recurrent infections as biofilms confer antibiotic resistance to pathogenic bacteria and protect them from the host’s immune system. Thus, it is imperative to investigate effective therapeutic agents to counteract biofilms. As an important signaling molecule, Nitric Oxide (NO) plays a crucial role in various biological and pathological processes. NO could disperse biofilm and restore the drug sensitivity by reducing intracellular cyclic-diguanosine monophosphate (c-di-GMP) levels. This review highlights recent advances on antibacterial and antibiofilm effects of NO when NO was co-administered with other antimicrobial agents. A significant improvement in drug permeability and biofilm cell targeting and reduced cytotoxicity could be attained with this strategy. In this review, we briefly lay out challenges and propose future directions in this appealing avenue of research on NO-based therapy for biofilm eradication.
Export Options
About this article
Cite this article as:
Yuan Mingke , Sun Tao , Wu Jianbing , Fei Yue , Yang Yueqi , Ling Yong , Zhang Yihua and Huang Zhangjian *, The Insights and Perspectives of Nitric Oxide-mediated Biofilm Eradication, Current Topics in Medicinal Chemistry 2021; 21 (24) . https://dx.doi.org/10.2174/1568026621666210701113043
DOI https://dx.doi.org/10.2174/1568026621666210701113043 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Approaches for Dominant Muscle Diseases: Highlight on Myotonic Dystrophy
Current Gene Therapy Biologic Therapies in Primary Sjögren's Syndrome
Current Pharmaceutical Biotechnology Transmission and Immunopathogenesis of FIV in Cats as a Model for HIV
Current HIV Research Bladder Cancer: A Simple Model Becomes Complex
Current Genomics Heat Shock Proteins: Therapeutic Drug Targets for Chronic Neurodegeneration?
Current Pharmaceutical Biotechnology Targeting Strategies in Therapeutic Applications of Toxoplasmosis: Recent Advances in Liposomal Vaccine Delivery Systems
Current Drug Targets MicroRNAs: Modulators of Tooth Development
MicroRNA Rationalizing the Study of Plants for the Treatment of Oral Pain
Current Chemical Biology Carbon Nanotubes as an Advanced Drug and Gene Delivery Nanosystem
Current Nanoscience “The Future Magic Bullet”: A Review of Pharmacological Activities of Ethyl Pyruvate and its Derivatives
Current Drug Therapy Flavonoids, Vascular Function and Cardiovascular Protection
Current Pharmaceutical Design The Role of Microbiota and Intestinal Permeability in the Pathophysiology of Autoimmune and Neuroimmune Processes with an Emphasis on Inflammatory Bowel Disease Type 1 Diabetes and Chronic Fatigue Syndrome
Current Pharmaceutical Design The New Immunosuppression: Intervention at the Dendritic Cell-T-Cell Interface
Current Drug Targets - Immune, Endocrine & Metabolic Disorders “Endothelial Progenitor Cells” as a Therapeutic Strategy in Cardiovascular Disease
Current Vascular Pharmacology Extraction Methods for Obtaining Carotenoids from Vegetables - Review
Current Analytical Chemistry Neurobiological Underpinnings of the Estrogen - Mood Relationship
Current Psychiatry Reviews Targeting Heat Shock Proteins 70/90 and Proteasome for Cancer Therapy
Current Medicinal Chemistry Therapeutic Applications of Liposomal Based Drug Delivery and Drug Targeting for Immune Linked Inflammatory Maladies: A Contemporary View Point
Current Drug Targets Perinatal Gene Transfer to the Liver
Current Pharmaceutical Design Amyloidosis and Auto-Inflammatory Syndromes
Current Drug Targets - Inflammation & Allergy